Jian Yan

6.6k citations
132 papers · 3.5k indexed · 1 hit paper · h-index 36

Impact in

  • Virology top 1%
    • HIV Research and Treatment
  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • HIV Research and Treatment 20
    • Immunotherapy and Immune Responses 36
    • Immune Cell Function and Interaction 18

Jian Yan

130 papers receiving 3.5k citations

Hit Papers

Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial 2024 · 111 citations
111202420262025255075100

Peers

Jian Yan
Comparison fields: 5 of 121
  • Virology 460
  • Immunology 1.7k
  • Biotechnology 382
  • Hepatology 257
  • Epidemiology 1.1k
Replace Annalisa D’Andrea with:
Annalisa D’Andrea United States
Gary T. Jennings Switzerland
Jan Pravsgaard Christensen Denmark
Gary R. Klimpel United States
A M Krieg United States
Stanley F. Wolf United States
Stephen J. McSorley United States
Hao Shen United States
Ae‐Kyung Yi United States
Giorgio Napolitani United Kingdom
Jian Yan relative to Annalisa D’Andrea United States Annalisa D’Andrea's profile →
Citations per field
00.5×2.6×
Annalisa D’Andrea · 1×
Citations per year

Countries citing papers authored by Jian Yan

Since Specialization
Citations

This map shows the geographic impact of Jian Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jian Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jian Yan more than expected).

Fields of papers citing papers by Jian Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jian Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jian Yan. The network helps show where Jian Yan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jian Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jian Yan Line = papers co-authored together Jian Yan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20242
2
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial
Hit paper breakdown →
2024111
3 20201
4 201836
5 201734
6 2017125
7 201527
8 2014111
9 201414
10 201321
11 2012229
12 20112
13 201133
14 201128
15 2009128
16
Study of the Chemical Constituents of Rauvolfia Vomitoria Afzel
20081
17 200837
18 200618
19 20061
20 200216

About Jian Yan

Jian Yan is a scholar working on Virology, Immunology, Biotechnology, Hepatology and Otorhinolaryngology, having authored 132 papers that have together received 3.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (36 papers), HIV Research and Treatment (20 papers), Immune Cell Function and Interaction (18 papers), vaccines and immunoinformatics approaches (12 papers), Hepatitis B Virus Studies (12 papers), Transgenic Plants and Applications (12 papers), Influenza Virus Research Studies (10 papers) and Cervical Cancer and HPV Research (10 papers). The work is most often cited by research in Virology (460 citations), Immunology (1.7k citations), Biotechnology (382 citations), Hepatology (257 citations) and Epidemiology (1.1k citations). Jian Yan has collaborated with scholars based in United States, China and Switzerland. Frequent co-authors include David B. Weiner, Amir Sada Khan, Niranjan Y. Sardesai, Matthew P. Morrow, Ruxandra Draghia‐Akli, Dominick J. Laddy, Panyupa Pankhong, Megan C. Wise, Daniel O. Villarreal and Natasha Corbitt. Their work appears in journals such as Vaccine, Molecular Therapy, Human Vaccines & Immunotherapeutics, PLoS ONE and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026